Seegene USA

Seegene USA is a subsidiary of Seegene Inc., Korea, a global developer of multiplex molecular technologies and clinical molecular assay solutions for US labs. Its high multiplex Real-time PCR assays can simultaneously detect multiple targets for infectious diseases such as respiratory infections, STDs, vector-borne diseases, gastrointestinal infections, and more. Seegene’s 2019 SARS-CoV-2 nCoV Assay is FDA EUA. Seegene aims to support a healthy life for everyone by creating a proprietary high multiplex real-time PCR technologies and syndromic testing.